Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-02-10
1995-02-14
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514382, 514397, 514307, 548250, 548252, 548253, 548254, 5483121, 546144, A61K 3141, A61K 31415, C07D25704
Patent
active
053896610
ABSTRACT:
This invention relates to novel substituted imidazole and triazole derivatives which antagonize the binding of angiotensin II to its receptors. The compounds are useful in the treatment of hypertension, heart failure, glaucoma, and hyperaldosteronism. Methods of making the compounds, novel intermediates useful in the preparation of the compounds, pharmaceutical compositions containing the compounds, and methods of using them are also covered.
REFERENCES:
patent: 4355040 (1982-10-01), Furukawa et al.
patent: 5128355 (1992-07-01), Carini et al.
patent: 5138069 (1992-08-01), Carini et al.
CA 91:206563y The indentification . . . determinations, Inglis et al., p. 271, 1979.
CA 113:23919x Imidazolidine-2,4-dione . . . antagonists, Hemmi et al., p. 663, 1990.
Sircar Ila
Sircar Jagadish C.
Anderson Elizabeth M.
Lee Mary C.
McKane Joseph K.
Warner-Lambert & Company
LandOfFree
Imidazole and 1,2,4-triazole derivatives with angiotensin II ant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole and 1,2,4-triazole derivatives with angiotensin II ant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole and 1,2,4-triazole derivatives with angiotensin II ant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-288486